Company: STAA
Filing Date: 2025-09-22
Form Type: PX14A6G
Source: 0001193125-25-210012
Chunk: 0

Company: STAAR SURGICAL CO
Filing Date: 2025-09-22
Form: PX14A6G
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Submitted Pursuant to Rule 14a-6(g) (Amendment No. _)

| 1. | Name of the Registrant: |

STAAR SURGICAL CO

| 2. | Name of Person Relying on Exemption: |

Yunqi Capital Limited

| 3. | Address of Person Relying on Exemption: |

Unit 3703, 37/F, AIA Tower, 183 Electric Road, North Point, Hong Kong

| 4. | Written Materials. The following written material is attached hereto: |

Press release, dated September 22, 2025, attached hereto as Exhibit 1. * * * Written material is submitted voluntarily pursuant to Rule 14a-6(g)(1)promulgated under the Securities Exchange Act of 1934, as amended. This is not a solicitation of authority to vote any proxy. Yunqi Capital Limited (“Yunqi Capital”) is not asking for your proxy card and will not accept proxy cards if sent. The cost of this filing is being borne entirely by Yunqi Capital and its affiliates. PLEASE NOTE: Yunqi Capital is not asking for your proxy card and cannot accept your proxy card. Please DO NOT send us your proxy card. (Written material follows on next page)

Exhibit 1

Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon

Issues Open Letter to Shareholders Outlining Its Belief that the Proposed Merger Materially Undervalues STAAR

Contends that STAAR’s Board Failed In Its Responsibilities by Not Running a Thorough Process and Relying on Undue Skepticism about the Company’s Prospects

Shareholders Deserve Fair Value for the Company

HONG KONG, September 22, 2025 – Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an
investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR”) (NASDAQ:STAA), today announced its opposition to the Company’s proposed sale to Alcon Inc. (SIX/NYSE:ALC) on the terms announced on
August 5, 2025.

Yunqi Capital released